EP Patent

EP0001851A1 — Highly concentrated pharmaceutical formulations of steroids and processes for their preparation

Assigned to Akzo NV · Expires 1979-05-16 · 47y expired

What this patent protects

The invention reistse to highly concantrated liquid pharmacautical formulations of stsroids of the occtrane, and the omtrane, androstane and (19-nor) prognane series comprising tocol or a derivative thereof that is fluid se normal tomperature, or mixtures thereof, in an smount of…

USPTO Abstract

The invention reistse to highly concantrated liquid pharmacautical formulations of stsroids of the occtrane, and the omtrane, androstane and (19-nor) prognane series comprising tocol or a derivative thereof that is fluid se normal tomperature, or mixtures thereof, in an smount of at least 10% by weight of the formulation. and optionaly one or more of te usual suid cariers. such as vegetable oil, benzyl benzosts and/or benzyl alcohol.

Drugs covered by this patent

Patent Metadata

Patent number
EP0001851A1
Jurisdiction
EP
Classification
—
Expires
1979-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Akzo NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.